LND (N = 177,76.3%) | nLND (N = 55,23.7%) | P value | |
---|---|---|---|
Sex | |||
Female | 86 (48.6) | 19 (34.5) | 0.68 |
Male | 91 (51.4) | 36 (65.5) | |
Age (year) | |||
≤ 60 | 103 (58.2) | 32 (58.2) | 0.99 |
> 60 | 74 (41.8) | 23 (41.8) | |
BMI (kg/m2) | |||
< 25 | 105 (59.3) | 26 (47.3) | 0.12 |
≥ 25 | 72 (40.7) | 29 (52.7) | |
LNM positive | |||
Yes | 71 (40.1) | NA | |
No | 106 (59.9) | ||
LND number | |||
< 6 | 111 (62.7) | NA | |
≥ 6 | 66 (37.3) | ||
LNM number | |||
0 | 106 (60.6) | NA | |
1 to 3 | 50 (28.6) | ||
> 3 | 19 (10.9) | ||
POD time (day) | |||
≤ 9 | 76 (43.2) | 35 (63.6) | < 0.01 |
> 9 | 100 (56.8) | 20 (36.4) | |
HbsAg + | |||
Yes | 32 (18.7) | 9 (18.0) | 0.90 |
No | 139 (81.3) | 41 (82.0) | |
CEA (ng/mL) | |||
≤ 7 | 135 (80.4) | 46 (86.8) | 0.29 |
> 7 | 33 (19.6) | 7 (13.2) | |
CA19-9 (U/mL) | |||
≤ 75 | 75 (44.6) | 36 (75.0) | < 0.01 |
> 75 | 93 (55.4) | 12 (25.0) | |
ALT (U/L) | |||
≤ 50 | 137 (77.4) | 52 (94.5) | < 0.01 |
> 50 | 40 (22.6) | 3 (5.5) | |
TBIL (μmol/L) | |||
≤ 21 | 145 (81.9) | 48 (87.3) | 0.35 |
> 21 | 32 (18.1) | 7 (12.7) | |
ALB (g/L) | |||
< 35 | 18 (10.2) | 2 (3.6) | 0.13 |
≥ 35 | 159 (89.8) | 53 (96.4) | |
ASA Score | |||
≤ 2 | 159 (89.8) | 53 (96.4) | 0.13 |
> 2 | 18 (10.2) | 2 (3.6) | |
Cirrhosis | |||
No | 28 (15.8) | 16 (29.1) | 0.03 |
Yes | 149 (84.2) | 39 (70.9) | |
Comorbidity | |||
No | 99 (55.9) | 32 (58.2) | 0.77 |
Yes | 78 (44.1) | 23 (41.8) | |
Operation time (min) | |||
≤ 235 | 81 (45.8) | 42 (76.4) | < 0.01 |
> 235 | 96 (54.2) | 13 (23.6) | |
Blood loss (mL) | |||
≤ 300 | 85 (48.0) | 38 (69.1) | < 0.01 |
> 300 | 92 (52.0) | 17 (30.9) | |
Intraoperative blood transfusion | |||
No | 106 (59.9) | 42 (76.4) | 0.03 |
Yes | 71 (40.1) | 13 (23.6) | |
Tumor size (cm) | |||
≤ 6 | 99 (55.9) | 36 (65.5) | 0.21 |
> 6 | 78 (44.1) | 19 (34.5) | |
Multi-disease | |||
Yes | 33 (18.6) | 7 (12.7) | 0.31 |
No | 144 (81.4) | 48 (87.3) | |
Margin + | |||
Yes | 22 (12.4) | 2 (3.6) | 0.06 |
No | 155 (87.6) | 53 (96.4) | |
Differentiation | |||
Poorly | 70 (39.5) | 22 (40.0) | 0.95 |
Moderately + well | 107 (60.5) | 33 (60) | |
Vascular invasion | |||
Yes | 87 (49.2) | 15 (27.3) | < 0.01 |
No | 90 (50.8) | 40 (72.7) | |
Nerve invasion | |||
Yes | 60 (33.9) | 7 (12.7) | < 0.01 |
No | 117 (66.1) | 48 (87.3) | |
T stage | |||
T1 | 101 (57.1) | 47 (85.5) | < 0.01 |
> T1 | 76 (42.9) | 8 (14.5) | |
Adjuvant chemotherapy | |||
Yes | 66 (37.3) | 21 (38.2) | 0.90 |
No | 111 (62.7) | 34 (61.8) |